Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesDividends payablesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to $3.6 million.

  • cbdMD's Other Non-Current Assets fell 3021.03% to $3.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.6 million, marking a year-over-year decrease of 3021.03%. This contributed to the annual value of $3.9 million for FY2025, which is 772.48% down from last year.
  • Latest data reveals that cbdMD reported Other Non-Current Assets of $3.6 million as of Q4 2025, which was down 3021.03% from $3.9 million recorded in Q3 2025.
  • In the past 5 years, cbdMD's Other Non-Current Assets registered a high of $88.4 million during Q3 2021, and its lowest value of $3.6 million during Q4 2025.
  • Over the past 5 years, cbdMD's median Other Non-Current Assets value was $15.5 million (recorded in 2023), while the average stood at $29.3 million.
  • As far as peak fluctuations go, cbdMD's Other Non-Current Assets surged by 143.52% in 2021, and later crashed by 7196.2% in 2022.
  • Quarter analysis of 5 years shows cbdMD's Other Non-Current Assets stood at $69.6 million in 2021, then plummeted by 65.26% to $24.2 million in 2022, then crashed by 68.06% to $7.7 million in 2023, then plummeted by 32.95% to $5.2 million in 2024, then tumbled by 30.21% to $3.6 million in 2025.
  • Its Other Non-Current Assets stands at $3.6 million for Q4 2025, versus $3.9 million for Q3 2025 and $4.3 million for Q2 2025.